β-Adrenergic receptor stimulation increases surface NKCC2 expression in rat thick ascending limbs in a process inhibited by phosphodiesterase 4

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 9, 2012, Pages

  Haque, Mohammed Z ^a   Caceres, Paulo S ^a,b   Ortiz, Pablo A ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Isoproterenol; PDE4; Rolipram; Sodium reabsorption

Indexed keywords

EID: 84868372198     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00019.2012     Document Type: Article

References (62)

1. Afzal F, Aronsen JM, Moltzau LR, Sjaastad I, Levy FO, Skomedal T, Osnes JB, Qvigstad E. Differential regulation of beta2-adrenoceptormediated inotropic and lusitropic response by PDE3 and PDE4 in failing and nonfailing rat cardiac ventricle. Br J Pharmacol 162: 54-71, 2011.
2. + cotransport in rat medullary thick ascending limb by dopamine. Am J Physiol Regul Integr Comp Physiol 271: R1561-R1567, 1996.
3. Ares GR, Caceres P, Alvarez-Leefmans FJ, Ortiz PA. cGMP decreases surface NKCC2 levels in the thick ascending limb: role of phosphodiesterase 2 (PDE2). Am J Physiol Renal Physiol 295: F877-F887, 2008.
4. Ares GR, Ortiz PA. Constitutive endocytosis and recycling of NKCC2 in rat thick ascending limbs. Am J Physiol Renal Physiol 299: F1193-F1202, 2010.
5. Baillie GS, Adams DR, Bhari N, Houslay TM, Vadrevu S, Meng D, Li X, Dunlop A, Milligan G, Bolger GB, Klussmann E, Houslay MD. Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N-and C-domains of beta-arrestin using spot-immobilized peptide arrays. Biochem J 404: 71-80, 2007.
6. Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, Lefkowitz RJ, Houslay MD. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci USA 100: 940-945, 2003.
7. Bailly C, Imbert-Teboul M, Roinel N, Amiel C. Isoproterenol increases Ca, Mg, and NaCl reabsorption in mouse thick ascending limb. Am J Physiol Renal Fluid Electrolyte Physiol 258: F1224-F1231, 1990.
8. Baum M. Effect of catecholamines on rat medullary thick ascending limb chloride transport: interaction with angiotensin II. Am J Physiol Regul Integr Comp Physiol 298: R954-R958, 2010.
9. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75: 725-748, 1995.
10. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520, 2006.
11. Bruss MD, Richter W, Horner K, Jin SL, Conti M. Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts. J Biol Chem 283: 22430-22442, 2008.
12. Caceres PS, Ares GR, Ortiz PA. cAMP stimulates apical exocytosis of the renal Na(+)-K(+)-2Cl(+) cotransporter NKCC2 in the thick ascending limb: role of protein kinase A. J Biol Chem 284: 24965-24971, 2009.
13. Cheung YF, Kan Z, Garrett-Engele P, Gall I, Murdoch H, Baillie GS, Camargo LM, Johnson JM, Houslay MD, Castle JC. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6). J Pharmacol Exp Ther 322: 600-609, 2007.
14. DiBona GF. The kidney in the pathogenesis of hypertension: the role of renal nerves. Am J Kidney Dis 5: A27-A31, 1985.
15. 2O transport in Henle's loop of the rat. Am J Physiol Renal Fluid Electrolyte Physiol 243: F576-F580, 1982.
16. Dousa TP. Cyclic-3=,5=-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int 55: 29-62, 1999.
17. salpha gene. Am J Physiol Renal Physiol 277: F235-F244, 1999.
18. Elalouf JM, Buhler JM, Tessiot C, Bellanger AC, Dublineau I, de Rouffignac C. Predominant expression of beta 1-adrenergic receptor in the thick ascending limb of rat kidney. Absolute mRNA quantitation by reverse transcription and polymerase chain reaction. J Clin Invest 91: 264-272, 1993.
19. Eng B, Mukhopadhyay S, Vio CP, Pedraza PL, Hao S, Battula S, Sehgal PB, McGiff JC, Ferreri NR. Characterization of a long-term rat mTAL cell line. Am J Physiol Renal Physiol 293: F1413-F1422, 2007.
20. Farooqui SM, Zhang K, Makhay M, Jackson K, Farooqui SQ, Cherry JA, O'Donnell JM. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain. Brain Res 867: 52-61, 2000.
21. Grande MT, Pascual G, Riolobos AS, Clemente-Lorenzo M, Bardaji B, Barreiro L, Tornavaca O, Meseguer A, Lopez-Novoa JM. Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice. Free Radic Biol Med 51: 1831-1841, 2011.
22. Gunaratne R, Braucht DW, Rinschen MM, Chou CL, Hoffert JD, Pisitkun T, Knepper MA. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells. Proc Natl Acad Sci USA 107: 15653-15658, 2010.
23. Haque MZ, Ares GR, Caceres PS, Ortiz PA. High salt differentially regulates surface NKCC2 expression in thick ascending limbs of dahl salt sensitive and salt resistant rats. Am J Physiol Renal Physiol 300: F1096-F1104, 2011.
24. Hebert SC, Andreoli TE. Control of NaCl transport in the thick ascending limb. Am J Physiol Renal Fluid Electrolyte Physiol 246: F745-F756, 1984.
25. Hebert SC, Friedman PA, Andreoli TE. Effects of antidiuretic hormone on cellular conductive pathways in mouse medullary thick ascending limbs of Henle: I. ADH increases transcellular conductance pathways. J Membr Biol 80: 201-219, 1984.
26. Heimann E, Jones HA, Resjo S, Manganiello VC, Stenson L, Degerman E. Expression and regulation of cyclic nucleotide phosphodiesterases in human and rat pancreatic islets. PLos One 5: e14191, 2010.
27. Houslay MD, Schafer P, Zhang KY. Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10: 1503-1519, 2005.
28. Johnston LA, Erdogan S, Cheung YF, Sullivan M, Barber R, Lynch MJ, Baillie GS, Van HG, Adams DR, Huston E, Houslay MD. Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase gene. Biochem J 380: 371-384, 2004.
29. Ke H. Implications of PDE4 structure on inhibitor selectivity across PDE families. Int J Impot Res 16, Suppl 1: S24-S27, 2004.
30. Keravis T, Monneaux F, Yougbare I, Gazi L, Bourguignon JJ, Muller S, Lugnier C. Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor. PLos One 7: e28899, 2012.
31. Kim GH, Ecelbarger CA, Mitchell C, Packer RK, Wade JB, Knepper MA. Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. Am J Physiol Renal Physiol 276: F96-F103, 1999.
32. Kim JK, Jackson BA, Edwards RM, Dousa TP. Effect of potassium depletion on the vasopressin-sensitive cyclic AMP system in rat outer medullary tubules. J Lab Clin Med 99: 29-38, 1982.
33. Kirchner KA. Increased loop chloride uptake precedes hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 262: R263-R268, 1992.
34. Kolosionek E, Savai R, Ghofrani HA, Weissmann N, Guenther A, Grimminger F, Seeger W, Banat GA, Schermuly RT, Pullamsetti SS. Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. Mol Biol Cell 20: 4751-4765, 2009.
35. Kopp UC, Cicha MZ, Smith LA, Ruohonen S, Scheinin M, Fritz N, Hokfelt T. Dietary sodium modulates the interaction between efferent and afferent renal nerve activity by altering activation of alpha2-adrenoceptors on renal sensory nerves. Am J Physiol Regul Integr Comp Physiol 300: R298-R310, 2011.
36. Lohmeier TE. The sympathetic nervous system and long-term blood pressure regulation. Am J Hypertens 14: 147S-154S, 2001.
37. Mackenzie KF, Topping EC, Bugaj-Gaweda B, Deng C, Cheung YF, Olsen AE, Stockard CR, High ML, Baillie GS, Grizzle WE, De VM, Houslay MD, Wang D, Bolger GB. Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change. Biochem J 411: 361-369, 2008.
38. McSorley T, Stefan E, Henn V, Wiesner B, Baillie GS, Houslay MD, Rosenthal W, Klussmann E. Spatial organisation of AKAP18 and PDE4 isoforms in renal collecting duct principal cells. Eur J Cell Biol 85: 673-678, 2006.
39. Meister B, Dagerlind A, Nicholas AP, Hokfelt T. Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney. J Pharmacol Exp Ther 268: 1605-1611, 1994.
40. Mohuczy-Dominiak D, Garg LC. Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney. J Pharmacol Exp Therapeut 266: 279-287, 1993.
41. Morgunov NS, You YD, Hirsch DJ. Response of mouse proximal straight tubule and medullary thick ascending limb to beta-agonist. J Am Soc Nephrol 4: 1151-1158, 1993.
42. Obernolte R, Ratzliff J, Baecker PA, Daniels DV, Zuppan P, Jarnagin K, Shelton ER. Multiple splice variants of phosphodiesterase PDE4C cloned from human lung and testis. Biochim Biophys Acta 1353: 287-297, 1997.
43. Ortiz PA. cAMP increases surface expression of NKCC2 in rat thick ascending limbs: role of VAMP. Am J Physiol Renal Physiol 290: F608-F616, 2006.
44. Ortiz PA, Garvin JL. NO Inhibits NaCl Absorption by Rat Thick Ascending Limb Through Activation of cGMP-Stimulated Phosphodiesterase. Hypertension 37: 467-471, 2001.
45. Owens RJ, Lumb S, Rees-Milton K, Russell A, Baldock D, Lang V, Crabbe T, Ballesteros M, Perry MJ. Molecular cloning and expression of a human phosphodiesterase 4C. Cell Signal 9: 575-585, 1997.
46. Perry SJ, Baillie GS, Kohout TA, McPhee I, Magiera MM, Ang KL, Miller WE, McLean AJ, Conti M, Houslay MD, Lefkowitz RJ. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298: 834-836, 2002.
47. + cotransporter. Am J Physiol Renal Physiol 280: F574-F582, 2001.
48. Plato CF. Alpha-2 and beta-adrenergic receptors mediate NE's biphasic effects on rat thick ascending limb chloride flux. Am J Physiol Regul Integr Comp Physiol 281: R979-R986, 2001.
49. Plato CF, Garvin JL. Alpha(2)-adrenergic-mediated tubular NO production inhibits thick ascending limb chloride absorption. Am J Physiol Renal Physiol 281: F679-F686, 2001.
50. Pullamsetti SS, Banat GA, Schmall A, Szibor M, Pomagruk D, Hanze J, Kolosionek E, Wilhelm J, Braun T, Grimminger F, Seeger W, Schermuly RT, Savai R. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF. Oncogene 2012 Apr 23 [Epub ahead of print].
51. Richter W, Jin SL, Conti M. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue. Biochem J 388: 803-811, 2005.
52. Shepherd M, McSorley T, Olsen AE, Johnston LA, Thomson NC, Baillie GS, Houslay MD, Bolger GB. Molecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoform. Biochem J 370: 429-438, 2003.
53. Sjoquist M, Lee SL, Hansell P. CNS-induced natriuresis, neurohypophyseal peptides and renal dopamine and noradrenaline excretion in prehypertensive salt-sensitive Dahl rats. Exp Physiol 90: 847-853, 2005.
54. Somova LI, Channa ML, Khan MS. An experimental rat model of salt-sensitive hypertension; biochemical and morphological parameters and sympathetic nervous system. J S Afr Vet Assoc 70: 14-17, 1999.
55. Sonalker PA, Tofovic SP, Bastacky SI, Jackson EK. Chronic noradrenaline increases renal expression of NHE-3, NBC-1, BSC-1 and aquaporin-Clin Exp Pharmacol Physiol 35: 594-600, 2008.
56. Sonalker PA, Tofovic SP, Jackson EK. Increased expression of the sodium transporter BSC-1 in spontaneously hypertensive rats. J Pharmacol Exp Ther 311: 1052-1061, 2004.
57. Stefan E, Wiesner B, Baillie GS, Mollajew R, Henn V, Lorenz D, Furkert J, Santamaria K, Nedvetsky P, Hundsrucker C, Beyermann M, Krause E, Pohl P, Gall I, MacIntyre AN, Bachmann S, Houslay MD, Rosenthal W, Klussmann E. Compartmentalization of cAMPdependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J Am Soc Nephrol 18: 199-212, 2007.
58. Struyker-Boudier HA, Vervoort-Peters LH, Rousch MJ, Smits JF, Thijssen HH. Beta-adrenoceptors in kidney tubules of spontaneously hypertensive and normotensive rats. Life Sci 38: 137-145, 1986.
59. Tawar U, Kotlo K, Jain S, Shukla S, Setty S, Danziger RS. Renal phosphodiesterase 4B is activated in the Dahl salt-sensitive rat. Hypertension 51: 762-766, 2008.
60. Xin W, Tran TM, Richter W, Clark RB, Rich TC. Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling. J Gen Physiol 131: 349-364, 2008.
61. Yougbare I, Morin C, Senouvo FY, Sirois C, Albadine R, Lugnier C, Rousseau E. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues. Am J Physiol Lung Cell Mol Physiol 301: L441-L450, 2011.
62. 2-Adrenergic receptor-mediated increase in NO production buffers renal medullary vasoconstriction. Am J Physiol Regul Integr Comp Physiol 279: R769-R777, 2000.